Adaptive Biotechnologies Corporation - Common Stock — Cash Flow (NASDAQ:ADPT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -149.68 M-192.73 M-183.94 M-156.32 M-95.21 M-45.99 M -27.04 M Cash from investing activities -117.04 M181.21 M2.9 M129.65 M77.79 M37.95 M 21.52 M Cash from financing activities 293.59 M27.15 M132.26 M2.25 M241 K30.4 M 32.45 M Free cash flow -149.68 M-192.73 M-183.94 M-156.32 M-95.21 M-48.95 M -29.54 M

News

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight

Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT

Adaptive Biotechnologies at TD Cowen Conference: Strategic Growth Insights

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript

Adeptus Biotechnologies stock price target raised to $21 by TD Cowen

Thursday’s Insider Activity: Cavco Director Buys as Execs Sell Off

Adaptive Biotechnologies Corporation 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ADPT) 2026-02-06